Showing results (121-130 of 256) with videos related to

Sort By:
Pageof 26
European Journal of Nuclear Medicine and Molecular Imaging|December 2, 2008
Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritisM A Kropholler, R Boellaard, E H Elzinga, et al.
Annals of the Rheumatic Diseases|June 24, 2006
Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritisC J van der Laken, A E Voskuyl, J C Roos, et al.
The Journal of Rheumatology|January 17, 2015
Objective evaluation of physical functioning after tumor necrosis factor inhibitory therapy in patients with ankylosing spondylitis: a selection of 3 feasible performance-based testsSalima F E van Weely, Joost Dekker, Martijn P M Steultjens, et al.
Rheumatology (Oxford, England)|July 30, 2009
Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitisSalima F E van Weely, Christiaan J van Denderen, Irene E van der Horst-Bruinsma, et al.
The Journal of Rheumatology|July 4, 2008
Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritisMike J L Peters, Vokko P van Halm, Michael T Nurmohamed, et al.
The Journal of Rheumatology|October 11, 2002
Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritisAnnemarie L M A Jansen, Irene van der Horst-Bruinsma, Dirkjan van Schaardenburg, et al.
Arthritis Care & Research|September 10, 2011
Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trialL Dirven, M Güler-Yüksel, W M de Beus, et al.
Clinical and Experimental Rheumatology|August 11, 2004
Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential yearsL M A Jansen, I E van der Horst-Bruinsma, D van Schaardenburg, et al.
The Journal of Rheumatology|February 5, 2005
Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritisMarijn Vis, Michael T Nurmohamed, Gertjan Wolbink, et al.
Annals of the Rheumatic Diseases|November 19, 2009
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritisI C van Eijk, M E Tushuizen, A Sturk, et al.
Pageof 26